CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 230 filers reported holding CONMED CORP in Q1 2023. The put-call ratio across all filers is 3.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,691,089 | +4.1% | 16,767 | +40.3% | 0.00% | -33.3% |
| Q2 2023 | $1,624,291 | +21.9% | 11,952 | -6.8% | 0.00% | 0.0% |
| Q1 2023 | $1,332,130 | +39.9% | 12,823 | +19.3% | 0.00% | +50.0% |
| Q4 2022 | $952,382 | +4.3% | 10,751 | -5.7% | 0.00% | 0.0% |
| Q3 2022 | $913,000 | -0.7% | 11,396 | +18.8% | 0.00% | 0.0% |
| Q2 2022 | $919,000 | -49.8% | 9,593 | -6.5% | 0.00% | -50.0% |
| Q1 2022 | $1,829,000 | +30.6% | 10,257 | +3.9% | 0.00% | +33.3% |
| Q4 2021 | $1,400,000 | +31.6% | 9,874 | +21.5% | 0.00% | +50.0% |
| Q3 2021 | $1,064,000 | +8.1% | 8,130 | +13.6% | 0.00% | 0.0% |
| Q2 2021 | $984,000 | +8.4% | 7,157 | +3.0% | 0.00% | 0.0% |
| Q1 2021 | $908,000 | +42.1% | 6,948 | +21.7% | 0.00% | 0.0% |
| Q4 2020 | $639,000 | -17.5% | 5,707 | -41.9% | 0.00% | 0.0% |
| Q3 2020 | $775,000 | +37.9% | 9,829 | +26.3% | 0.00% | 0.0% |
| Q2 2020 | $562,000 | +23.8% | 7,784 | -1.8% | 0.00% | 0.0% |
| Q1 2020 | $454,000 | – | 7,928 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 27,500 | $2,437,600 | 2.23% |
| Ranger Investment Management | 316,318 | $28,038,428 | 2.08% |
| Lighthouse Investment Partners, LLC | 142,100 | $12,595,744 | 1.39% |
| Lighthouse Investment Partners, LLC | 139,200 | $12,338,688 | 1.36% |
| EARNEST PARTNERS LLC | 2,402,352 | $212,944,481 | 1.30% |
| Lighthouse Investment Partners, LLC | 108,200 | $9,590,848 | 1.06% |
| MOODY ALDRICH PARTNERS LLC | 51,885 | $4,599,086 | 0.93% |
| MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID | 125,435 | $11,118,558 | 0.81% |
| Champlain Investment Partners, LLC | 1,275,910 | $113,096,662 | 0.72% |
| EPIQ PARTNERS, LLC | 10,463 | $927,440 | 0.62% |